Bridgeport Hospital is a not-for-profit general medical and surgical hospital in Bridgeport, Connecticut. It is a member of Yale New Haven Health System and affiliated with Yale School of Medicine.

There are 501 beds in Bridgeport Hospital.

During the past decade, Bridgeport Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 29 clinical trials were completed, i.e. on average, 116% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 11 clinical trials were completed. i.e. 78.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bridgeport Hospital" #1 sponsor was "Radiation Therapy Oncology Group" with 11 trials, followed by "Yale University" with 8 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bridgeport Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Bridgeport Hospital" are "Breast Cancer" (10 trials), "Cardiovascular Disease" (4 trials), "Burns" (3 trials), "Heart Failure" (3 trials) and "Prostate Cancer" (3 trials). Many other conditions were trialed in "Bridgeport Hospital" in a lesser frequency.

Most popular intervention types in "Bridgeport Hospital" are "Drug" (50 trials), "Other" (14 trials), "Radiation" (14 trials), "Procedure" (9 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Laboratory Biomarker Analysis" (5 trials), "Anastrozole" (3 trials), "Bevacizumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bridgeport Hospital" are 64 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Bridgeport Hospital". undefined are not yet recruiting, 7 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Bridgeport Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Bridgeport Hospital, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

Bridgeport Hospital has several departments that took part in Clinical trials: "Connecticut Heart and Vascular Center" - 2 trials